Global Radiopharmaceutical for Nuclear Medicine Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Radiopharmaceutical for Nuclear Medicine market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Radiopharmaceutical for Nuclear Medicine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
This report is a detailed and comprehensive analysis for global Radiopharmaceutical for Nuclear Medicine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
- Global Radiopharmaceutical for Nuclear Medicine market size and forecasts, in consumption value ($ Million), 2021-2032
- Global Radiopharmaceutical for Nuclear Medicine market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
- Global Radiopharmaceutical for Nuclear Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
- Global Radiopharmaceutical for Nuclear Medicine market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Radiopharmaceutical for Nuclear Medicine
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Radiopharmaceutical for Nuclear Medicine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.Market segment by Type
- Carbon-14
- Technetium-99m
- Iodine-131
- Iodine-125
- Others
Market segment by Application
- Nuclear Medicine Diagnosis
- Nuclear Medicine Treatment
- Others
Market segment by players, this report covers
- NRG
- NTP Radioisotopes
- JSC Isotope
- ANSTO
- China National Nuclear Corporation (CNNC)
- IRE ELIT
- Nordion
- Polatom
Market segment by regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
- South America (Brazil, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
- Chapter 1, to describe Radiopharmaceutical for Nuclear Medicine product scope, market overview, market estimation caveats and base year.
- Chapter 2, to profile the top players of Radiopharmaceutical for Nuclear Medicine, with revenue, gross margin, and global market share of Radiopharmaceutical for Nuclear Medicine from 2021 to 2026.
- Chapter 3, the Radiopharmaceutical for Nuclear Medicine competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
- Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
- Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Radiopharmaceutical for Nuclear Medicine market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
- Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
- Chapter 12, the key raw materials and key suppliers, and industry chain of Radiopharmaceutical for Nuclear Medicine.
- Chapter 13, to describe Radiopharmaceutical for Nuclear Medicine research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Radiopharmaceutical for Nuclear Medicine by Type
1.3.1 Overview: Global Radiopharmaceutical for Nuclear Medicine Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Type in 2025
1.3.3 Carbon-14
1.3.4 Technetium-99m
1.3.5 Iodine-131
1.3.6 Iodine-125
1.3.7 Others
1.4 Global Radiopharmaceutical for Nuclear Medicine Market by Application
1.4.1 Overview: Global Radiopharmaceutical for Nuclear Medicine Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 Nuclear Medicine Diagnosis
1.4.3 Nuclear Medicine Treatment
1.4.4 Others
1.5 Global Radiopharmaceutical for Nuclear Medicine Market Size & Forecast
1.6 Global Radiopharmaceutical for Nuclear Medicine Market Size and Forecast by Region
1.6.1 Global Radiopharmaceutical for Nuclear Medicine Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Radiopharmaceutical for Nuclear Medicine Market Size by Region, (2021-2032)
1.6.3 North America Radiopharmaceutical for Nuclear Medicine Market Size and Prospect (2021-2032)
1.6.4 Europe Radiopharmaceutical for Nuclear Medicine Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Radiopharmaceutical for Nuclear Medicine Market Size and Prospect (2021-2032)
1.6.6 South America Radiopharmaceutical for Nuclear Medicine Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Radiopharmaceutical for Nuclear Medicine Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 NRG
2.1.1 NRG Details
2.1.2 NRG Major Business
2.1.3 NRG Radiopharmaceutical for Nuclear Medicine Product and Solutions
2.1.4 NRG Radiopharmaceutical for Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 NRG Recent Developments and Future Plans
2.2 NTP Radioisotopes
2.2.1 NTP Radioisotopes Details
2.2.2 NTP Radioisotopes Major Business
2.2.3 NTP Radioisotopes Radiopharmaceutical for Nuclear Medicine Product and Solutions
2.2.4 NTP Radioisotopes Radiopharmaceutical for Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 NTP Radioisotopes Recent Developments and Future Plans
2.3 JSC Isotope
2.3.1 JSC Isotope Details
2.3.2 JSC Isotope Major Business
2.3.3 JSC Isotope Radiopharmaceutical for Nuclear Medicine Product and Solutions
2.3.4 JSC Isotope Radiopharmaceutical for Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 JSC Isotope Recent Developments and Future Plans
2.4 ANSTO
2.4.1 ANSTO Details
2.4.2 ANSTO Major Business
2.4.3 ANSTO Radiopharmaceutical for Nuclear Medicine Product and Solutions
2.4.4 ANSTO Radiopharmaceutical for Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 ANSTO Recent Developments and Future Plans
2.5 China National Nuclear Corporation (CNNC)
2.5.1 China National Nuclear Corporation (CNNC) Details
2.5.2 China National Nuclear Corporation (CNNC) Major Business
2.5.3 China National Nuclear Corporation (CNNC) Radiopharmaceutical for Nuclear Medicine Product and Solutions
2.5.4 China National Nuclear Corporation (CNNC) Radiopharmaceutical for Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 China National Nuclear Corporation (CNNC) Recent Developments and Future Plans
2.6 IRE ELIT
2.6.1 IRE ELIT Details
2.6.2 IRE ELIT Major Business
2.6.3 IRE ELIT Radiopharmaceutical for Nuclear Medicine Product and Solutions
2.6.4 IRE ELIT Radiopharmaceutical for Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 IRE ELIT Recent Developments and Future Plans
2.7 Nordion
2.7.1 Nordion Details
2.7.2 Nordion Major Business
2.7.3 Nordion Radiopharmaceutical for Nuclear Medicine Product and Solutions
2.7.4 Nordion Radiopharmaceutical for Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Nordion Recent Developments and Future Plans
2.8 Polatom
2.8.1 Polatom Details
2.8.2 Polatom Major Business
2.8.3 Polatom Radiopharmaceutical for Nuclear Medicine Product and Solutions
2.8.4 Polatom Radiopharmaceutical for Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Polatom Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Radiopharmaceutical for Nuclear Medicine Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Radiopharmaceutical for Nuclear Medicine by Company Revenue
3.2.2 Top 3 Radiopharmaceutical for Nuclear Medicine Players Market Share in 2025
3.2.3 Top 6 Radiopharmaceutical for Nuclear Medicine Players Market Share in 2025
3.3 Radiopharmaceutical for Nuclear Medicine Market: Overall Company Footprint Analysis
3.3.1 Radiopharmaceutical for Nuclear Medicine Market: Region Footprint
3.3.2 Radiopharmaceutical for Nuclear Medicine Market: Company Product Type Footprint
3.3.3 Radiopharmaceutical for Nuclear Medicine Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Radiopharmaceutical for Nuclear Medicine Consumption Value and Market Share by Type (2021-2026)
4.2 Global Radiopharmaceutical for Nuclear Medicine Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Application (2021-2026)
5.2 Global Radiopharmaceutical for Nuclear Medicine Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2021-2032)
6.2 North America Radiopharmaceutical for Nuclear Medicine Market Size by Application (2021-2032)
6.3 North America Radiopharmaceutical for Nuclear Medicine Market Size by Country
6.3.1 North America Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2021-2032)
6.3.2 United States Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
6.3.3 Canada Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
6.3.4 Mexico Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2021-2032)
7.2 Europe Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2021-2032)
7.3 Europe Radiopharmaceutical for Nuclear Medicine Market Size by Country
7.3.1 Europe Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2021-2032)
7.3.2 Germany Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
7.3.3 France Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
7.3.5 Russia Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
7.3.6 Italy Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Radiopharmaceutical for Nuclear Medicine Market Size by Region
8.3.1 Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value by Region (2021-2032)
8.3.2 China Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
8.3.3 Japan Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
8.3.4 South Korea Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
8.3.5 India Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
8.3.7 Australia Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2021-2032)
9.2 South America Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2021-2032)
9.3 South America Radiopharmaceutical for Nuclear Medicine Market Size by Country
9.3.1 South America Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2021-2032)
9.3.2 Brazil Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
9.3.3 Argentina Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Radiopharmaceutical for Nuclear Medicine Market Size by Country
10.3.1 Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2021-2032)
10.3.2 Turkey Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
10.3.4 UAE Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Radiopharmaceutical for Nuclear Medicine Market Drivers
11.2 Radiopharmaceutical for Nuclear Medicine Market Restraints
11.3 Radiopharmaceutical for Nuclear Medicine Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Radiopharmaceutical for Nuclear Medicine Industry Chain
12.2 Radiopharmaceutical for Nuclear Medicine Upstream Analysis
12.3 Radiopharmaceutical for Nuclear Medicine Midstream Analysis
12.4 Radiopharmaceutical for Nuclear Medicine Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Radiopharmaceutical for Nuclear Medicine by Type
1.3.1 Overview: Global Radiopharmaceutical for Nuclear Medicine Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Type in 2025
1.3.3 Carbon-14
1.3.4 Technetium-99m
1.3.5 Iodine-131
1.3.6 Iodine-125
1.3.7 Others
1.4 Global Radiopharmaceutical for Nuclear Medicine Market by Application
1.4.1 Overview: Global Radiopharmaceutical for Nuclear Medicine Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 Nuclear Medicine Diagnosis
1.4.3 Nuclear Medicine Treatment
1.4.4 Others
1.5 Global Radiopharmaceutical for Nuclear Medicine Market Size & Forecast
1.6 Global Radiopharmaceutical for Nuclear Medicine Market Size and Forecast by Region
1.6.1 Global Radiopharmaceutical for Nuclear Medicine Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Radiopharmaceutical for Nuclear Medicine Market Size by Region, (2021-2032)
1.6.3 North America Radiopharmaceutical for Nuclear Medicine Market Size and Prospect (2021-2032)
1.6.4 Europe Radiopharmaceutical for Nuclear Medicine Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Radiopharmaceutical for Nuclear Medicine Market Size and Prospect (2021-2032)
1.6.6 South America Radiopharmaceutical for Nuclear Medicine Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Radiopharmaceutical for Nuclear Medicine Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 NRG
2.1.1 NRG Details
2.1.2 NRG Major Business
2.1.3 NRG Radiopharmaceutical for Nuclear Medicine Product and Solutions
2.1.4 NRG Radiopharmaceutical for Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 NRG Recent Developments and Future Plans
2.2 NTP Radioisotopes
2.2.1 NTP Radioisotopes Details
2.2.2 NTP Radioisotopes Major Business
2.2.3 NTP Radioisotopes Radiopharmaceutical for Nuclear Medicine Product and Solutions
2.2.4 NTP Radioisotopes Radiopharmaceutical for Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 NTP Radioisotopes Recent Developments and Future Plans
2.3 JSC Isotope
2.3.1 JSC Isotope Details
2.3.2 JSC Isotope Major Business
2.3.3 JSC Isotope Radiopharmaceutical for Nuclear Medicine Product and Solutions
2.3.4 JSC Isotope Radiopharmaceutical for Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 JSC Isotope Recent Developments and Future Plans
2.4 ANSTO
2.4.1 ANSTO Details
2.4.2 ANSTO Major Business
2.4.3 ANSTO Radiopharmaceutical for Nuclear Medicine Product and Solutions
2.4.4 ANSTO Radiopharmaceutical for Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 ANSTO Recent Developments and Future Plans
2.5 China National Nuclear Corporation (CNNC)
2.5.1 China National Nuclear Corporation (CNNC) Details
2.5.2 China National Nuclear Corporation (CNNC) Major Business
2.5.3 China National Nuclear Corporation (CNNC) Radiopharmaceutical for Nuclear Medicine Product and Solutions
2.5.4 China National Nuclear Corporation (CNNC) Radiopharmaceutical for Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 China National Nuclear Corporation (CNNC) Recent Developments and Future Plans
2.6 IRE ELIT
2.6.1 IRE ELIT Details
2.6.2 IRE ELIT Major Business
2.6.3 IRE ELIT Radiopharmaceutical for Nuclear Medicine Product and Solutions
2.6.4 IRE ELIT Radiopharmaceutical for Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 IRE ELIT Recent Developments and Future Plans
2.7 Nordion
2.7.1 Nordion Details
2.7.2 Nordion Major Business
2.7.3 Nordion Radiopharmaceutical for Nuclear Medicine Product and Solutions
2.7.4 Nordion Radiopharmaceutical for Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Nordion Recent Developments and Future Plans
2.8 Polatom
2.8.1 Polatom Details
2.8.2 Polatom Major Business
2.8.3 Polatom Radiopharmaceutical for Nuclear Medicine Product and Solutions
2.8.4 Polatom Radiopharmaceutical for Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Polatom Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Radiopharmaceutical for Nuclear Medicine Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Radiopharmaceutical for Nuclear Medicine by Company Revenue
3.2.2 Top 3 Radiopharmaceutical for Nuclear Medicine Players Market Share in 2025
3.2.3 Top 6 Radiopharmaceutical for Nuclear Medicine Players Market Share in 2025
3.3 Radiopharmaceutical for Nuclear Medicine Market: Overall Company Footprint Analysis
3.3.1 Radiopharmaceutical for Nuclear Medicine Market: Region Footprint
3.3.2 Radiopharmaceutical for Nuclear Medicine Market: Company Product Type Footprint
3.3.3 Radiopharmaceutical for Nuclear Medicine Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Radiopharmaceutical for Nuclear Medicine Consumption Value and Market Share by Type (2021-2026)
4.2 Global Radiopharmaceutical for Nuclear Medicine Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Application (2021-2026)
5.2 Global Radiopharmaceutical for Nuclear Medicine Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2021-2032)
6.2 North America Radiopharmaceutical for Nuclear Medicine Market Size by Application (2021-2032)
6.3 North America Radiopharmaceutical for Nuclear Medicine Market Size by Country
6.3.1 North America Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2021-2032)
6.3.2 United States Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
6.3.3 Canada Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
6.3.4 Mexico Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2021-2032)
7.2 Europe Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2021-2032)
7.3 Europe Radiopharmaceutical for Nuclear Medicine Market Size by Country
7.3.1 Europe Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2021-2032)
7.3.2 Germany Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
7.3.3 France Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
7.3.5 Russia Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
7.3.6 Italy Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Radiopharmaceutical for Nuclear Medicine Market Size by Region
8.3.1 Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value by Region (2021-2032)
8.3.2 China Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
8.3.3 Japan Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
8.3.4 South Korea Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
8.3.5 India Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
8.3.7 Australia Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2021-2032)
9.2 South America Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2021-2032)
9.3 South America Radiopharmaceutical for Nuclear Medicine Market Size by Country
9.3.1 South America Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2021-2032)
9.3.2 Brazil Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
9.3.3 Argentina Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Radiopharmaceutical for Nuclear Medicine Market Size by Country
10.3.1 Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2021-2032)
10.3.2 Turkey Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
10.3.4 UAE Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Radiopharmaceutical for Nuclear Medicine Market Drivers
11.2 Radiopharmaceutical for Nuclear Medicine Market Restraints
11.3 Radiopharmaceutical for Nuclear Medicine Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Radiopharmaceutical for Nuclear Medicine Industry Chain
12.2 Radiopharmaceutical for Nuclear Medicine Upstream Analysis
12.3 Radiopharmaceutical for Nuclear Medicine Midstream Analysis
12.4 Radiopharmaceutical for Nuclear Medicine Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Radiopharmaceutical for Nuclear Medicine Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Radiopharmaceutical for Nuclear Medicine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Radiopharmaceutical for Nuclear Medicine Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Radiopharmaceutical for Nuclear Medicine Consumption Value by Region (2027-2032) & (USD Million)
Table 5. NRG Company Information, Head Office, and Major Competitors
Table 6. NRG Major Business
Table 7. NRG Radiopharmaceutical for Nuclear Medicine Product and Solutions
Table 8. NRG Radiopharmaceutical for Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. NRG Recent Developments and Future Plans
Table 10. NTP Radioisotopes Company Information, Head Office, and Major Competitors
Table 11. NTP Radioisotopes Major Business
Table 12. NTP Radioisotopes Radiopharmaceutical for Nuclear Medicine Product and Solutions
Table 13. NTP Radioisotopes Radiopharmaceutical for Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. NTP Radioisotopes Recent Developments and Future Plans
Table 15. JSC Isotope Company Information, Head Office, and Major Competitors
Table 16. JSC Isotope Major Business
Table 17. JSC Isotope Radiopharmaceutical for Nuclear Medicine Product and Solutions
Table 18. JSC Isotope Radiopharmaceutical for Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. ANSTO Company Information, Head Office, and Major Competitors
Table 20. ANSTO Major Business
Table 21. ANSTO Radiopharmaceutical for Nuclear Medicine Product and Solutions
Table 22. ANSTO Radiopharmaceutical for Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. ANSTO Recent Developments and Future Plans
Table 24. China National Nuclear Corporation (CNNC) Company Information, Head Office, and Major Competitors
Table 25. China National Nuclear Corporation (CNNC) Major Business
Table 26. China National Nuclear Corporation (CNNC) Radiopharmaceutical for Nuclear Medicine Product and Solutions
Table 27. China National Nuclear Corporation (CNNC) Radiopharmaceutical for Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. China National Nuclear Corporation (CNNC) Recent Developments and Future Plans
Table 29. IRE ELIT Company Information, Head Office, and Major Competitors
Table 30. IRE ELIT Major Business
Table 31. IRE ELIT Radiopharmaceutical for Nuclear Medicine Product and Solutions
Table 32. IRE ELIT Radiopharmaceutical for Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. IRE ELIT Recent Developments and Future Plans
Table 34. Nordion Company Information, Head Office, and Major Competitors
Table 35. Nordion Major Business
Table 36. Nordion Radiopharmaceutical for Nuclear Medicine Product and Solutions
Table 37. Nordion Radiopharmaceutical for Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Nordion Recent Developments and Future Plans
Table 39. Polatom Company Information, Head Office, and Major Competitors
Table 40. Polatom Major Business
Table 41. Polatom Radiopharmaceutical for Nuclear Medicine Product and Solutions
Table 42. Polatom Radiopharmaceutical for Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Polatom Recent Developments and Future Plans
Table 44. Global Radiopharmaceutical for Nuclear Medicine Revenue (USD Million) by Players (2021-2026)
Table 45. Global Radiopharmaceutical for Nuclear Medicine Revenue Share by Players (2021-2026)
Table 46. Breakdown of Radiopharmaceutical for Nuclear Medicine by Company Type (Tier 1, Tier 2, and Tier 3)
Table 47. Market Position of Players in Radiopharmaceutical for Nuclear Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 48. Head Office of Key Radiopharmaceutical for Nuclear Medicine Players
Table 49. Radiopharmaceutical for Nuclear Medicine Market: Company Product Type Footprint
Table 50. Radiopharmaceutical for Nuclear Medicine Market: Company Product Application Footprint
Table 51. Radiopharmaceutical for Nuclear Medicine New Market Entrants and Barriers to Market Entry
Table 52. Radiopharmaceutical for Nuclear Medicine Mergers, Acquisition, Agreements, and Collaborations
Table 53. Global Radiopharmaceutical for Nuclear Medicine Consumption Value (USD Million) by Type (2021-2026)
Table 54. Global Radiopharmaceutical for Nuclear Medicine Consumption Value Share by Type (2021-2026)
Table 55. Global Radiopharmaceutical for Nuclear Medicine Consumption Value Forecast by Type (2027-2032)
Table 56. Global Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2021-2026)
Table 57. Global Radiopharmaceutical for Nuclear Medicine Consumption Value Forecast by Application (2027-2032)
Table 58. North America Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2021-2026) & (USD Million)
Table 59. North America Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2027-2032) & (USD Million)
Table 60. North America Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2021-2026) & (USD Million)
Table 61. North America Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2027-2032) & (USD Million)
Table 62. North America Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2021-2026) & (USD Million)
Table 63. North America Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2027-2032) & (USD Million)
Table 64. Europe Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2021-2026) & (USD Million)
Table 65. Europe Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2027-2032) & (USD Million)
Table 66. Europe Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2021-2026) & (USD Million)
Table 67. Europe Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2027-2032) & (USD Million)
Table 68. Europe Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2021-2026) & (USD Million)
Table 69. Europe Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2027-2032) & (USD Million)
Table 70. Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2027-2032) & (USD Million)
Table 72. Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2027-2032) & (USD Million)
Table 74. Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value by Region (2021-2026) & (USD Million)
Table 75. Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value by Region (2027-2032) & (USD Million)
Table 76. South America Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2021-2026) & (USD Million)
Table 77. South America Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2027-2032) & (USD Million)
Table 78. South America Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2021-2026) & (USD Million)
Table 79. South America Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2027-2032) & (USD Million)
Table 80. South America Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2021-2026) & (USD Million)
Table 81. South America Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2027-2032) & (USD Million)
Table 82. Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2027-2032) & (USD Million)
Table 84. Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2027-2032) & (USD Million)
Table 86. Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2021-2026) & (USD Million)
Table 87. Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2027-2032) & (USD Million)
Table 88. Global Key Players of Radiopharmaceutical for Nuclear Medicine Upstream (Raw Materials)
Table 89. Global Radiopharmaceutical for Nuclear Medicine Typical Customers
Table 1. Global Radiopharmaceutical for Nuclear Medicine Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Radiopharmaceutical for Nuclear Medicine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Radiopharmaceutical for Nuclear Medicine Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Radiopharmaceutical for Nuclear Medicine Consumption Value by Region (2027-2032) & (USD Million)
Table 5. NRG Company Information, Head Office, and Major Competitors
Table 6. NRG Major Business
Table 7. NRG Radiopharmaceutical for Nuclear Medicine Product and Solutions
Table 8. NRG Radiopharmaceutical for Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. NRG Recent Developments and Future Plans
Table 10. NTP Radioisotopes Company Information, Head Office, and Major Competitors
Table 11. NTP Radioisotopes Major Business
Table 12. NTP Radioisotopes Radiopharmaceutical for Nuclear Medicine Product and Solutions
Table 13. NTP Radioisotopes Radiopharmaceutical for Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. NTP Radioisotopes Recent Developments and Future Plans
Table 15. JSC Isotope Company Information, Head Office, and Major Competitors
Table 16. JSC Isotope Major Business
Table 17. JSC Isotope Radiopharmaceutical for Nuclear Medicine Product and Solutions
Table 18. JSC Isotope Radiopharmaceutical for Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. ANSTO Company Information, Head Office, and Major Competitors
Table 20. ANSTO Major Business
Table 21. ANSTO Radiopharmaceutical for Nuclear Medicine Product and Solutions
Table 22. ANSTO Radiopharmaceutical for Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. ANSTO Recent Developments and Future Plans
Table 24. China National Nuclear Corporation (CNNC) Company Information, Head Office, and Major Competitors
Table 25. China National Nuclear Corporation (CNNC) Major Business
Table 26. China National Nuclear Corporation (CNNC) Radiopharmaceutical for Nuclear Medicine Product and Solutions
Table 27. China National Nuclear Corporation (CNNC) Radiopharmaceutical for Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. China National Nuclear Corporation (CNNC) Recent Developments and Future Plans
Table 29. IRE ELIT Company Information, Head Office, and Major Competitors
Table 30. IRE ELIT Major Business
Table 31. IRE ELIT Radiopharmaceutical for Nuclear Medicine Product and Solutions
Table 32. IRE ELIT Radiopharmaceutical for Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. IRE ELIT Recent Developments and Future Plans
Table 34. Nordion Company Information, Head Office, and Major Competitors
Table 35. Nordion Major Business
Table 36. Nordion Radiopharmaceutical for Nuclear Medicine Product and Solutions
Table 37. Nordion Radiopharmaceutical for Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Nordion Recent Developments and Future Plans
Table 39. Polatom Company Information, Head Office, and Major Competitors
Table 40. Polatom Major Business
Table 41. Polatom Radiopharmaceutical for Nuclear Medicine Product and Solutions
Table 42. Polatom Radiopharmaceutical for Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Polatom Recent Developments and Future Plans
Table 44. Global Radiopharmaceutical for Nuclear Medicine Revenue (USD Million) by Players (2021-2026)
Table 45. Global Radiopharmaceutical for Nuclear Medicine Revenue Share by Players (2021-2026)
Table 46. Breakdown of Radiopharmaceutical for Nuclear Medicine by Company Type (Tier 1, Tier 2, and Tier 3)
Table 47. Market Position of Players in Radiopharmaceutical for Nuclear Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 48. Head Office of Key Radiopharmaceutical for Nuclear Medicine Players
Table 49. Radiopharmaceutical for Nuclear Medicine Market: Company Product Type Footprint
Table 50. Radiopharmaceutical for Nuclear Medicine Market: Company Product Application Footprint
Table 51. Radiopharmaceutical for Nuclear Medicine New Market Entrants and Barriers to Market Entry
Table 52. Radiopharmaceutical for Nuclear Medicine Mergers, Acquisition, Agreements, and Collaborations
Table 53. Global Radiopharmaceutical for Nuclear Medicine Consumption Value (USD Million) by Type (2021-2026)
Table 54. Global Radiopharmaceutical for Nuclear Medicine Consumption Value Share by Type (2021-2026)
Table 55. Global Radiopharmaceutical for Nuclear Medicine Consumption Value Forecast by Type (2027-2032)
Table 56. Global Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2021-2026)
Table 57. Global Radiopharmaceutical for Nuclear Medicine Consumption Value Forecast by Application (2027-2032)
Table 58. North America Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2021-2026) & (USD Million)
Table 59. North America Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2027-2032) & (USD Million)
Table 60. North America Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2021-2026) & (USD Million)
Table 61. North America Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2027-2032) & (USD Million)
Table 62. North America Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2021-2026) & (USD Million)
Table 63. North America Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2027-2032) & (USD Million)
Table 64. Europe Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2021-2026) & (USD Million)
Table 65. Europe Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2027-2032) & (USD Million)
Table 66. Europe Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2021-2026) & (USD Million)
Table 67. Europe Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2027-2032) & (USD Million)
Table 68. Europe Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2021-2026) & (USD Million)
Table 69. Europe Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2027-2032) & (USD Million)
Table 70. Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2027-2032) & (USD Million)
Table 72. Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2027-2032) & (USD Million)
Table 74. Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value by Region (2021-2026) & (USD Million)
Table 75. Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value by Region (2027-2032) & (USD Million)
Table 76. South America Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2021-2026) & (USD Million)
Table 77. South America Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2027-2032) & (USD Million)
Table 78. South America Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2021-2026) & (USD Million)
Table 79. South America Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2027-2032) & (USD Million)
Table 80. South America Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2021-2026) & (USD Million)
Table 81. South America Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2027-2032) & (USD Million)
Table 82. Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2027-2032) & (USD Million)
Table 84. Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2027-2032) & (USD Million)
Table 86. Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2021-2026) & (USD Million)
Table 87. Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2027-2032) & (USD Million)
Table 88. Global Key Players of Radiopharmaceutical for Nuclear Medicine Upstream (Raw Materials)
Table 89. Global Radiopharmaceutical for Nuclear Medicine Typical Customers
LIST OF FIGURES
Figure 1. Radiopharmaceutical for Nuclear Medicine Picture
Figure 2. Global Radiopharmaceutical for Nuclear Medicine Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Type in 2025
Figure 4. Carbon-14
Figure 5. Technetium-99m
Figure 6. Iodine-131
Figure 7. Iodine-125
Figure 8. Others
Figure 9. Global Radiopharmaceutical for Nuclear Medicine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 10. Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Application in 2025
Figure 11. Nuclear Medicine Diagnosis Picture
Figure 12. Nuclear Medicine Treatment Picture
Figure 13. Others Picture
Figure 14. Global Radiopharmaceutical for Nuclear Medicine Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 15. Global Radiopharmaceutical for Nuclear Medicine Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 16. Global Market Radiopharmaceutical for Nuclear Medicine Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 17. Global Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Region (2021-2032)
Figure 18. Global Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Region in 2025
Figure 19. North America Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 20. Europe Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 21. Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 22. South America Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 23. Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 24. Company Three Recent Developments and Future Plans
Figure 25. Global Radiopharmaceutical for Nuclear Medicine Revenue Share by Players in 2025
Figure 26. Radiopharmaceutical for Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 27. Market Share of Radiopharmaceutical for Nuclear Medicine by Player Revenue in 2025
Figure 28. Top 3 Radiopharmaceutical for Nuclear Medicine Players Market Share in 2025
Figure 29. Top 6 Radiopharmaceutical for Nuclear Medicine Players Market Share in 2025
Figure 30. Global Radiopharmaceutical for Nuclear Medicine Consumption Value Share by Type (2021-2026)
Figure 31. Global Radiopharmaceutical for Nuclear Medicine Market Share Forecast by Type (2027-2032)
Figure 32. Global Radiopharmaceutical for Nuclear Medicine Consumption Value Share by Application (2021-2026)
Figure 33. Global Radiopharmaceutical for Nuclear Medicine Market Share Forecast by Application (2027-2032)
Figure 34. North America Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Type (2021-2032)
Figure 35. North America Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Application (2021-2032)
Figure 36. North America Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Country (2021-2032)
Figure 37. United States Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 38. Canada Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 39. Mexico Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 40. Europe Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Type (2021-2032)
Figure 41. Europe Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Application (2021-2032)
Figure 42. Europe Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Country (2021-2032)
Figure 43. Germany Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 44. France Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 45. United Kingdom Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 46. Russia Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 47. Italy Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 48. Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Type (2021-2032)
Figure 49. Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Application (2021-2032)
Figure 50. Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Region (2021-2032)
Figure 51. China Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 52. Japan Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 53. South Korea Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 54. India Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 55. Southeast Asia Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 56. Australia Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 57. South America Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Type (2021-2032)
Figure 58. South America Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Application (2021-2032)
Figure 59. South America Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Country (2021-2032)
Figure 60. Brazil Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 61. Argentina Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 62. Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Type (2021-2032)
Figure 63. Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Application (2021-2032)
Figure 64. Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Country (2021-2032)
Figure 65. Turkey Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 66. Saudi Arabia Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 67. UAE Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 68. Radiopharmaceutical for Nuclear Medicine Market Drivers
Figure 69. Radiopharmaceutical for Nuclear Medicine Market Restraints
Figure 70. Radiopharmaceutical for Nuclear Medicine Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Radiopharmaceutical for Nuclear Medicine Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Radiopharmaceutical for Nuclear Medicine Picture
Figure 2. Global Radiopharmaceutical for Nuclear Medicine Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Type in 2025
Figure 4. Carbon-14
Figure 5. Technetium-99m
Figure 6. Iodine-131
Figure 7. Iodine-125
Figure 8. Others
Figure 9. Global Radiopharmaceutical for Nuclear Medicine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 10. Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Application in 2025
Figure 11. Nuclear Medicine Diagnosis Picture
Figure 12. Nuclear Medicine Treatment Picture
Figure 13. Others Picture
Figure 14. Global Radiopharmaceutical for Nuclear Medicine Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 15. Global Radiopharmaceutical for Nuclear Medicine Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 16. Global Market Radiopharmaceutical for Nuclear Medicine Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 17. Global Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Region (2021-2032)
Figure 18. Global Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Region in 2025
Figure 19. North America Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 20. Europe Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 21. Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 22. South America Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 23. Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 24. Company Three Recent Developments and Future Plans
Figure 25. Global Radiopharmaceutical for Nuclear Medicine Revenue Share by Players in 2025
Figure 26. Radiopharmaceutical for Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 27. Market Share of Radiopharmaceutical for Nuclear Medicine by Player Revenue in 2025
Figure 28. Top 3 Radiopharmaceutical for Nuclear Medicine Players Market Share in 2025
Figure 29. Top 6 Radiopharmaceutical for Nuclear Medicine Players Market Share in 2025
Figure 30. Global Radiopharmaceutical for Nuclear Medicine Consumption Value Share by Type (2021-2026)
Figure 31. Global Radiopharmaceutical for Nuclear Medicine Market Share Forecast by Type (2027-2032)
Figure 32. Global Radiopharmaceutical for Nuclear Medicine Consumption Value Share by Application (2021-2026)
Figure 33. Global Radiopharmaceutical for Nuclear Medicine Market Share Forecast by Application (2027-2032)
Figure 34. North America Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Type (2021-2032)
Figure 35. North America Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Application (2021-2032)
Figure 36. North America Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Country (2021-2032)
Figure 37. United States Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 38. Canada Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 39. Mexico Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 40. Europe Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Type (2021-2032)
Figure 41. Europe Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Application (2021-2032)
Figure 42. Europe Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Country (2021-2032)
Figure 43. Germany Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 44. France Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 45. United Kingdom Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 46. Russia Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 47. Italy Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 48. Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Type (2021-2032)
Figure 49. Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Application (2021-2032)
Figure 50. Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Region (2021-2032)
Figure 51. China Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 52. Japan Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 53. South Korea Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 54. India Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 55. Southeast Asia Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 56. Australia Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 57. South America Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Type (2021-2032)
Figure 58. South America Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Application (2021-2032)
Figure 59. South America Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Country (2021-2032)
Figure 60. Brazil Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 61. Argentina Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 62. Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Type (2021-2032)
Figure 63. Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Application (2021-2032)
Figure 64. Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Country (2021-2032)
Figure 65. Turkey Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 66. Saudi Arabia Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 67. UAE Radiopharmaceutical for Nuclear Medicine Consumption Value (2021-2032) & (USD Million)
Figure 68. Radiopharmaceutical for Nuclear Medicine Market Drivers
Figure 69. Radiopharmaceutical for Nuclear Medicine Market Restraints
Figure 70. Radiopharmaceutical for Nuclear Medicine Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Radiopharmaceutical for Nuclear Medicine Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
